Colossal Biosciences Secures $200M Funding with $10.2B Valuation for Revolutionary De-extinction Efforts
Colossal Biosciences led by CEO and co-founder, Ben Lamm, has successfully bagged a formidable $200 million in Series C funding…
Colossal Biosciences led by CEO and co-founder, Ben Lamm, has successfully bagged a formidable $200 million in Series C funding…